Designing telemedicine apps that health commissioners will adopt

A. Marshall
{"title":"Designing telemedicine apps that health commissioners will adopt","authors":"A. Marshall","doi":"10.1109/FRUCT.2013.6737946","DOIUrl":null,"url":null,"abstract":"In countries with a national health service, new telemedicine and telehealth products and services are `commissioned' according to a fairly rigorous and regulated process, that usually involves pilot studies and the assembly of `evidence' to show that the innovation offers performance and/or cost advantages. This is problematic for several reasons and means that many innovations are piloted and performance evaluated, but relatively few pass into mainstream adoption. The current relationship between healthcare commissioners and technology developers is adversarial rather than collaborative. Evaluations and regulatory systems place the responsibility with the developer to prove that the solution works - in other words, to refute the assumption that the solution may not be appropriate. Furthermore, with telemedicine innovations the `user' and the `customer' is not a single individual or organisation - the healthcare professional, the patient (and perhaps carer, family or friends), as well as the organisation itself are all involved. A conventional evaluation ignores the organisationally disruptive aspect of the technology. A better question than `does it work?' would be `how can we use it?' This paper reviews barriers to adoption and considers the particular issues that developers of telemedicine apps need to address. We propose the Stakeholder Empowered Adoption (SEA) Model, as a process that builds stakeholder (staff and patients, managers, technologists) perspectives into the specification and early design stages and uses scenario modelling and simulations to avoid dependence on actual prototypes. The model recognises that the main economic stakeholders (the health organisation commissioning the innovation and the technology provider) need to drive the process, but end users (professionals and patients) are critical t","PeriodicalId":169672,"journal":{"name":"14th Conference of Open Innovation Association FRUCT","volume":"280 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"14th Conference of Open Innovation Association FRUCT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/FRUCT.2013.6737946","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

In countries with a national health service, new telemedicine and telehealth products and services are `commissioned' according to a fairly rigorous and regulated process, that usually involves pilot studies and the assembly of `evidence' to show that the innovation offers performance and/or cost advantages. This is problematic for several reasons and means that many innovations are piloted and performance evaluated, but relatively few pass into mainstream adoption. The current relationship between healthcare commissioners and technology developers is adversarial rather than collaborative. Evaluations and regulatory systems place the responsibility with the developer to prove that the solution works - in other words, to refute the assumption that the solution may not be appropriate. Furthermore, with telemedicine innovations the `user' and the `customer' is not a single individual or organisation - the healthcare professional, the patient (and perhaps carer, family or friends), as well as the organisation itself are all involved. A conventional evaluation ignores the organisationally disruptive aspect of the technology. A better question than `does it work?' would be `how can we use it?' This paper reviews barriers to adoption and considers the particular issues that developers of telemedicine apps need to address. We propose the Stakeholder Empowered Adoption (SEA) Model, as a process that builds stakeholder (staff and patients, managers, technologists) perspectives into the specification and early design stages and uses scenario modelling and simulations to avoid dependence on actual prototypes. The model recognises that the main economic stakeholders (the health organisation commissioning the innovation and the technology provider) need to drive the process, but end users (professionals and patients) are critical t
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
设计卫生专员将采用的远程医疗应用程序
在拥有国家卫生服务的国家,新的远程医疗和远程保健产品和服务是根据相当严格和规范的程序“委托”的,这通常涉及试点研究和收集“证据”,以表明创新提供了性能和/或成本优势。这是有问题的,有几个原因,这意味着许多创新是试点和性能评估,但相对较少进入主流采用。目前,医疗保健专员和技术开发人员之间的关系是对抗的,而不是合作的。评估和管理系统将证明解决方案有效的责任置于开发人员身上——换句话说,驳斥解决方案可能不合适的假设。此外,通过远程医疗创新,“用户”和“客户”不是一个单独的个人或组织——医疗保健专业人员、患者(可能还有护理人员、家人或朋友)以及组织本身都参与其中。传统的评估忽略了技术对组织的破坏性方面。这是一个比“它有效吗?”,应该是“我们如何使用它?”本文回顾了采用的障碍,并考虑了远程医疗应用程序开发人员需要解决的特定问题。我们提出了利益相关者授权采用(SEA)模型,作为一个将利益相关者(员工和患者、管理人员、技术人员)的观点构建到规范和早期设计阶段的过程,并使用场景建模和模拟来避免对实际原型的依赖。该模型认识到,主要的经济利益相关者(委托创新的卫生组织和技术提供者)需要推动这一过程,但最终用户(专业人员和患者)至关重要
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
MneMojno — Design and deployment of a Semantic web service and a mobile application Energy aware power save mode management in wireless mesh networks The research platform for building medical diagnostic services Development of smart room services on top of Smart-M3 Designing telemedicine apps that health commissioners will adopt
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1